-
Synthetic Insulin-Producing Cells Designed, Tested
Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin.
-
IBM, Rice Univ. Partner on Elder Care Robots
IBM is developing Watson super-computer and cloud computing applications with Rice University to create robot assistants that help older individuals remain safe in their own homes.
-
LEDs Shown to Reduce Alzheimer’s Brain Plaques
Pulsating LED lights were shown in lab mice to reduce amyloid-beta plaque deposits associated with Alzheimer’s disease on brain cells, with the lead researchers starting a company to commercialize the technology.
-
NantHealth, TransMed Partner on Cancer Genomics
Two companies offering medical analytics aim to provide cancer specialists with individualized genomic analyses for their patients, and more access to clinical trials.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Trial to Test Radio Waves to Treat Alzheimer’s
A clinical trial is inviting individuals with Alzheimer’s disease to test a device that its designers claim can reverse cognitive impairment resulting from Alzheimer’s disease.
-
Many Health Apps Found Not Helping People in Need
Many mobile apps designed to help manage one’s health are not assisting people in most need of that help and often do not appropriately respond to information with dangerous consequences.
-
Why Personalization and Psychology are Crucial to Modern Ecommerce Stores
Putting your products and services online for the world to see is perhaps simpler than ever. But why are so many ecommerce brands struggling to make consistent sales?
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.
-
High Leukemia Remissions Reported for Engineered T-Cells
First results from an international clinical trial of engineered immune system cells to treat leukemia in children show high rates of remission, but also many severe adverse effects.